Example: Heart Attack

Clinical Trials on Chronic Graft Versus Host Disease

Total 264 results

NCT04200365

Recruiting

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft-versus-host-disease
NCT03790332

Recruiting

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft Versus Host Disease
NCT02291770

Unknown status

Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

Conditions: Chronic Graft-Versus-Host Disease
NCT04710576

Recruiting

A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft-versus-host-disease
NCT04189432

Recruiting

Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft-versus-host-disease
NCT01765660

Unknown status

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Conditions: Chronic Graft-versus-host Disease
NCT03483675

Active, not recruiting

Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

Conditions: Chronic Graft Versus Host Disease
NCT01964625

Terminated

Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)

Conditions: Chronic Graft Versus Host Disease
NCT02701634

Terminated

Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft Versus Host Disease
NCT03584516

Recruiting

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft-versus-host Disease
NCT01161628

Completed

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Conditions: Chronic Graft-versus-host Disease
NCT03007238

Active, not recruiting

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft Versus Host Disease
NCT03422627

Recruiting

Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Conditions: Chronic Graft Versus Host Disease cGVHD
NCT01680965

Active, not recruiting

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Conditions: Chronic Graft Versus Host Disease
NCT01954979

Active, not recruiting

A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Conditions: Chronic Graft Versus Host Disease
NCT02352064

Unknown status

Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH)

Conditions: Chronic Graft Versus Host Disease
NCT02337517

Terminated

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft Versus Host Disease
NCT03083574

Recruiting

Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Conditions: Refractory Chronic Graft Versus Host Disease (cGVHD)
NCT03415867

Active, not recruiting

Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease

Conditions: Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
NCT02749084

Recruiting

Multiple Donor Treg DLI for Severe Refractory Chronic GVHD

Conditions: Chronic Graft Versus Host Disease
NCT01028313

Withdrawn

A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft-Versus-Host Disease
NCT02123966

Terminated

An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease

Conditions: Chronic Graft-versus-Host-Disease; Oral Mucosal Disease Due to Graft-versus-host Disease
NCT01862965

Completed

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus

Conditions: Chronic Graft-versus-host Disease
NCT01366092

Active, not recruiting

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Conditions: Chronic Graft-versus-host Disease
NCT01526850

Unknown status

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease

Conditions: Chronic Graft Versus Host Disease